Document and Entity Information
Document and Entity Information | Mar. 21, 2024 |
Cover [Abstract] | |
Amendment Flag | false |
Entity Central Index Key | 0001505512 |
Document Type | 8-K |
Document Period End Date | Mar. 21, 2024 |
Entity Registrant Name | Regulus Therapeutics Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-35670 |
Entity Tax Identification Number | 26-4738379 |
Entity Address, Address Line One | 4224 Campus Point Court |
Entity Address, Address Line Two | Suite 210 |
Entity Address, City or Town | San Diego |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92121 |
City Area Code | (858) |
Local Phone Number | 202-6300 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.001 per share |
Trading Symbol | RGLS |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |